Accessibility Menu
 
Sartorius Aktiengesellschaft logo

Sartorius Aktiengesellschaft

(ETR) SRT

Current Price$167.60
Market Cap$11.67B
Since IPO (1992)+24,888%
5 Year-56%
1 Year-3%
1 Month-13%

Sartorius Aktiengesellschaft Financials at a Glance

Market Cap

$11.67B

Revenue (TTM)

$3.54B

Net Income (TTM)

$155.00M

EPS (TTM)

$2.25

P/E Ratio

75.28

Dividend

$0.73

Beta (Volatility)

-0.07 (Low)

Price

$167.60

Volume

120

Open

$168.00

Previous Close

$168.27

Daily Range

$167.20 - $168.00

52-Week Range

$131.40 - $208.00

SRT News

No articles available.

SRT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sartorius Aktiengesellschaft

Industry

Life Sciences Tools and Services

Employees

14,042

CEO

Michael Grosse, PhD

Headquarters

Göttingen, 37079, DE

SRT Financials

Key Financial Metrics (TTM)

Gross Margin

46%

Operating Margin

16%

Net Income Margin

4%

Return on Equity

6%

Return on Capital

7%

Return on Assets

2%

Earnings Yield

1.33%

Dividend Yield

0.00%

Payout Ratio

32.71%

Stock Overview

Market Cap

$11.67B

Shares Outstanding

69.05M

Volume

120

Short Interest

0.00%

Avg. Volume

4.12K

Financials (TTM)

Gross Profit

$1.64B

Operating Income

$651.40M

EBITDA

$1.07B

Operating Cash Flow

$656.00M

Capital Expenditure

$441.90M

Free Cash Flow

$214.10M

Cash & ST Invst.

$541.40M

Total Debt

$4.45B

Sartorius Aktiengesellschaft Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$927.60M

+2.3%

Gross Profit

$396.40M

+0.5%

Gross Margin

42.73%

N/A

Market Cap

$11.67B

N/A

Market Cap/Employee

$859.78K

N/A

Employees

13,573

N/A

Net Income

$30.20M

-32.0%

EBITDA

$267.20M

+79.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.91B

-4.9%

Accounts Receivable

$291.70M

-25.4%

Inventory

$792.20M

+0.5%

Long Term Debt

$3.53B

-15.3%

Short Term Debt

$926.40M

+135.7%

Return on Assets

1.60%

N/A

Return on Invested Capital

7.40%

N/A

Free Cash Flow

$170.90M

-37.3%

Operating Cash Flow

$307.80M

-15.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FME.DEFresenius Medical Care AG & Co. KGaA
$38.78-0.41%
CBHD.DEColoplast A/S
$58.60+0.86%
GE9.FGenmab A/S
$228.80+1.06%
QIA.DEQiagen N.V.
$34.94-0.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$171.28-0.04%
NOKNokia
$8.28-0.02%
TSLATesla
$372.24-0.04%
AMDAdvanced Micro Devices
$203.89-0.07%

Questions About SRT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.